The 6th Annual Rare and Genetic Kidney Disease Drug Development Summit is dedicated to the development of therapeutic treatments in PKD, IgA, FSGS, Alport Syndrome and more.
Key Topics
Applications of microRNA as a treatment for ADPKD, Alport Syndrome, FSGS, IgAN and more
New diagnostic tools beyond creatinine, proteinuria, and total kidney
Evidence to achieve FDA’s full approval of a biologic and demonstrate long-term efficacy
Disease modelling of genetic kidney diseases through stem cell-derived kidney organoids
Venue
Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, United States
6th Annual Rare and Genetic Kidney Disease Drug Development Summit - 18-20 Aug 2026, Revere Hotel Boston Common, Massachusetts, United States (95850)
7th Annual Rare and Genetic Kidney Disease Drug Development Summit - 2027, Boston, Massachusetts, United States (94009)
Important
Please, check "Rare and Genetic Kidney Disease Drug Development Summit" official website for possible changes, before making any traveling arrangements
